AIkido Pharma (AIKI) Competitors $3.53 -0.39 (-9.95%) As of 04/3/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrendsBuy This Stock AIKI vs. NOTV, LUNA, ONMD, BIAF, DKDCA, ISPC, IQV, ICLR, INCY, and MEDPShould you be buying AIkido Pharma stock or one of its competitors? The main competitors of AIkido Pharma include Inotiv (NOTV), Luna Innovations (LUNA), OneMedNet (ONMD), bioAffinity Technologies (BIAF), Data Knights Acquisition (DKDCA), iSpecimen (ISPC), IQVIA (IQV), ICON Public (ICLR), Incyte (INCY), and Medpace (MEDP). These companies are all part of the "commercial physical research" industry. AIkido Pharma vs. Inotiv Luna Innovations OneMedNet bioAffinity Technologies Data Knights Acquisition iSpecimen IQVIA ICON Public Incyte Medpace Inotiv (NASDAQ:NOTV) and AIkido Pharma (NASDAQ:AIKI) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, community ranking, earnings, dividends, media sentiment, valuation, profitability and institutional ownership. Does the media refer more to NOTV or AIKI? In the previous week, Inotiv's average media sentiment score of 0.00 equaled AIkido Pharma'saverage media sentiment score. Company Overall Sentiment Inotiv Neutral AIkido Pharma Neutral Which has more risk & volatility, NOTV or AIKI? Inotiv has a beta of 3.96, meaning that its share price is 296% more volatile than the S&P 500. Comparatively, AIkido Pharma has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500. Is NOTV or AIKI more profitable? AIkido Pharma has a net margin of 0.00% compared to Inotiv's net margin of -25.40%. Inotiv's return on equity of -15.41% beat AIkido Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Inotiv-25.40% -15.41% -3.58% AIkido Pharma N/A -18.21%-16.94% Does the MarketBeat Community prefer NOTV or AIKI? AIkido Pharma received 82 more outperform votes than Inotiv when rated by MarketBeat users. Likewise, 63.92% of users gave AIkido Pharma an outperform vote while only 48.72% of users gave Inotiv an outperform vote. CompanyUnderperformOutperformInotivOutperform Votes1948.72% Underperform Votes2051.28% AIkido PharmaOutperform Votes10163.92% Underperform Votes5736.08% Do analysts rate NOTV or AIKI? Inotiv presently has a consensus target price of $5.92, indicating a potential upside of 151.77%. Given Inotiv's stronger consensus rating and higher probable upside, research analysts plainly believe Inotiv is more favorable than AIkido Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inotiv 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67AIkido Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals have more ownership in NOTV or AIKI? 18.2% of Inotiv shares are held by institutional investors. Comparatively, 10.9% of AIkido Pharma shares are held by institutional investors. 7.8% of Inotiv shares are held by insiders. Comparatively, 8.6% of AIkido Pharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has preferable valuation and earnings, NOTV or AIKI? AIkido Pharma has lower revenue, but higher earnings than Inotiv. AIkido Pharma is trading at a lower price-to-earnings ratio than Inotiv, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInotiv$475.11M0.17-$108.44M-$4.61-0.51AIkido Pharma$10K1,936.21-$7.17M-$3.88-0.91 SummaryInotiv beats AIkido Pharma on 9 of the 16 factors compared between the two stocks. Remove Ads Get AIkido Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AIKI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIKI vs. The Competition Export to ExcelMetricAIkido PharmaCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$19.36M$3.12B$5.24B$7.11BDividend YieldN/A2.31%4.89%4.05%P/E Ratio-0.9192.9721.1917.45Price / Sales1,936.21103.41356.8485.26Price / CashN/A34.5738.1834.64Price / Book0.182.396.243.79Net Income-$7.17M$113.28M$3.20B$247.10M7 Day Performance-26.15%-0.10%-8.29%-6.72%1 Month Performance-47.63%-18.86%-4.69%-11.41%1 Year Performance25.62%-17.95%2.67%-7.74% AIkido Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIKIAIkido PharmaN/A$3.53-9.9%N/A+46.5%$19.36M$10,000.00-0.914Gap DownHigh Trading VolumeNOTVInotiv2.1982 of 5 stars$2.21+2.8%$5.92+167.7%-67.3%$74.52M$475.11M-0.482,100Positive NewsGap DownLUNALuna Innovations1.2184 of 5 stars$0.68-2.9%$8.00+1,076.5%-82.7%$23.09M$116.61M0.00390Analyst ForecastONMDOneMedNetN/A$0.54-3.6%N/A-47.8%$15.11M$957,651.000.002Upcoming EarningsBIAFbioAffinity Technologies1.5556 of 5 stars$0.26-0.7%$6.00+2,207.7%-73.5%$4.05M$9.37M-0.3210Earnings ReportUpcoming EarningsAnalyst ForecastNews CoverageHigh Trading VolumeDKDCAData Knights AcquisitionN/A$0.56-2.8%N/A-41.8%$2.90MN/A-2.952Gap DownISPCiSpecimen0.4952 of 5 stars$1.06-7.8%N/A+425.3%$1.02M$10.39M-0.0660Positive NewsIQVIQVIA4.8069 of 5 stars$176.28-0.6%$249.05+41.3%-35.2%$31.08B$15.41B23.5086,000Positive NewsGap DownICLRICON Public4.1647 of 5 stars$174.99-2.3%$272.50+55.7%-50.9%$14.13B$8.28B18.3641,100Gap DownINCYIncyte4.6029 of 5 stars$60.55-0.1%$74.88+23.7%+10.2%$11.72B$4.24B224.272,320Positive NewsMEDPMedpace4.6799 of 5 stars$304.69-2.5%$376.30+23.5%-26.2%$9.28B$2.11B24.125,900Short Interest ↓News CoveragePositive NewsGap DownHigh Trading Volume Remove Ads Related Companies and Tools Related Companies Inotiv Alternatives Luna Innovations Alternatives OneMedNet Alternatives bioAffinity Technologies Alternatives Data Knights Acquisition Alternatives iSpecimen Alternatives IQVIA Alternatives ICON Public Alternatives Incyte Alternatives Medpace Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AIKI) was last updated on 4/5/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIkido Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIkido Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
